Approval · Notice of Compliance 18558 · 2016
CORVERT: Notice of Compliance 18558
Issued October 4, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18558
- Date
- October 4, 2016
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change the product name from 'corvert injection' to 'corvert'
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORVERT | 02242470 | Marketed |
Medicinal ingredients
- IBUTILIDE FUMARATE 0.1 MG per ML